Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals Enthorin Therapeutics, LLC, a ...

A missing brain molecule may be disrupting neural wiring in Down syndrome, according to new research. Replacing it in adult mice rewired brain circuits and improved brain flexibility, challenging the ...

The final, formatted version of the article will be published soon. Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability (ID). However, its diagnostic rate needs to ...

Comedian Amy Schumer, 44, has recently come clean about her struggle with Cushing’s syndrome, leading to a dramatic weight loss. Schumer's transformation has sparked conversation online, to which she ...

Laura Dern’s scowl is one of the great wonders of American movies. Her mouth flattens into a blade, her eyes constrict into lasers, and you tense up instinctively, as if you might get caught in the ...

Children with fragile X syndrome display widespread differences in brain morphology, including larger gray matter volume in subcortical regions and distinct brain-behavior correlations. Children with ...

NEW YORK, Dec 2 (Reuters) - The U.S. holiday shopping season kicked off to record online sales. But underlying signs of economic fragility signal a pullback in spending could be looming. Consumer ...

Mirum Pharmaceuticals MIRM announced that it has enrolled the first patient in the phase II BLOOM study evaluating its newly in-licensed PDE4D inhibitor, MRM-3379, for treating Fragile X syndrome (FXS ...

With similar symptoms, it can be difficult to tell which illness is which. Here’s what to know. By Dani Blum Early clues suggest that this flu season could be particularly brutal. And while national ...

BELEM, Brazil Nov 23 (Reuters) - In the final fractious hours of the U.N. climate summit in Brazil, when a deal to advance the world's fight against global warming was slipping out of reach, COP30 ...